China SXT Pharmaceuticals Inc (SXTC) vs. Its Peers: A Comparison
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has a price-to-earnings ratio of 0.33x that is above its average ratio. Additionally, the 36-month beta value for SXTC
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has a price-to-earnings ratio of 0.33x that is above its average ratio. Additionally, the 36-month beta value for SXTC
The stock price of China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has dropped by -6.50 compared to previous close of 0.64. Despite this, the company has
China SXT Pharmaceuticals Inc (NASDAQ: SXTC)’s stock price has dropped by -9.91 in relation to previous closing price of 0.67. Nevertheless, the company has seen
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has a price-to-earnings ratio that is above its average at 0.26x. The stock has a 36-month beta value of
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.